These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27497715)

  • 1. Newer Therapies for Amyloid Cardiomyopathy.
    Chakraborty R; Muchtar E; Gertz MA
    Curr Heart Fail Rep; 2016 Oct; 13(5):237-246. PubMed ID: 27497715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Amyloidosis Treatment.
    Stern LK; Patel J
    Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
    Thenappan T; Fedson S; Rich J; Murks C; Husain A; Pogoriler J; Anderson AS
    Amyloid; 2014 Jun; 21(2):120-3. PubMed ID: 24818650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the diagnosis and management of cardiac amyloidosis.
    Sher T; Gertz MA
    Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
    Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
    J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.
    Castaño A; Drachman BM; Judge D; Maurer MS
    Heart Fail Rev; 2015 Mar; 20(2):163-78. PubMed ID: 25408161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis: a treatable disease, often overlooked.
    Falk RH
    Circulation; 2011 Aug; 124(9):1079-85. PubMed ID: 21875922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy.
    Nuvolone M; Girelli M; Merlini G
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in the understanding and treatment of transthyretin amyloidosis.
    Sekijima Y
    J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid cardiomyopathy.
    Karafiatova L; Pika T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Jun; 161(2):117-127. PubMed ID: 28145535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the diagnosis and treatment of cardiac amyloidosis].
    Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G
    Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis: evolving approach to diagnosis and management.
    Meier-Ewert HK; Sanchorawala V; Berk JL; Ruberg FL
    Curr Treat Options Cardiovasc Med; 2011 Dec; 13(6):528-42. PubMed ID: 21989745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.
    Liepnieks JJ; Benson MD
    Amyloid; 2007 Dec; 14(4):277-82. PubMed ID: 17968687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.
    Rosenblum H; Castano A; Alvarez J; Goldsmith J; Helmke S; Maurer MS
    Circ Heart Fail; 2018 Apr; 11(4):e004769. PubMed ID: 29615436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.